Status:
RECRUITING
Spontaneous Coronary Artery Dissection National Swiss Registry
Lead Sponsor:
Dr. Sophie Degrauwe
Conditions:
Spontaneous Coronary Artery Dissection
Eligibility:
All Genders
18+ years
Brief Summary
Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse ...
Eligibility Criteria
Inclusion
- Subject is ≥18 years of age.
- Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years.
- Subject must be willing to sign a Patient Informed Consent (PIC).
Exclusion
- Patient unwilling or unable to provide informed consent.
- Patients with atherosclerotic or iatrogenic coronary dissection.
Key Trial Info
Start Date :
August 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04457544
Start Date
August 12 2020
End Date
June 30 2030
Last Update
November 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Switzerland, 1205